ACN241129P325000
- 0.04
- -0.06-60.00%
Accenture Newsroom
Analysts Offer Insights on Technology Companies: Wix (WIX), Accenture (ACN) and Vertex (VERX)
Endava in Focus as BofA Initiates Coverage
Accenture's Balanced Risk/Reward Profile and Modest Revenue Growth Lead to Hold Rating
BNP Paribas Downgrades Accenture(ACN.US) to Hold Rating, Cuts Target Price to $375
BNP Paribas Exane Downgrades Accenture to Neutral, Price Target Is $375
Cautious Outlook on Accenture: Hold Rating Amid Modest Growth and Valuation Concerns
Baird Maintains Accenture(ACN.US) With Hold Rating, Maintains Target Price $370
Accenture (ACN) Receives a Hold From Jefferies
Guggenheim Adjusts Price Target on Accenture to $345 From $395, Maintains Buy Rating
DBS Maintains Accenture(ACN.US) With Hold Rating, Raises Target Price to $360
Accenture Hold Rating: Balancing AI Growth Potential With Macroeconomic Challenges
Barclays Maintains Overweight on Accenture, Raises Price Target to $415
DA Davidson Raises Price Target on Accenture to $372 From $339, Keeps Buy/Add Rating
Barclays Maintains Accenture(ACN.US) With Buy Rating, Maintains Target Price $415
TD Cowen Upgrades Accenture(ACN.US) to Buy Rating, Raises Target Price to $400
Accenture: Poised for Growth With Buy Rating Amid Sector Recovery and Strategic Positioning
Baird raised Accenture's target price to $370.
A Quick Look at Today's Ratings for Accenture(ACN.US), With a Forecast Between $360 to $415
Accenture Is Maintained at Buy by UBS
Accenture Price Target Raised to $395.00/Share From $380.00 by Guggenheim